FSD Pharma Inc. Announces C$10.125 Million Private Placement
FSD Pharma Inc. (NASDAQ: HUGE) (FSD Pharma or the Company), today announced it has entered into definitive agreements with certain institutional investors for the purchase and sale of 1,500,000 shares of the Companys Class B Subordinate Voting Shares (Shares) at a price of C$6.75 per Share pursuant to a private placement resulting in gross proceeds of approximately C$10.125 million.
- FSD Pharma Inc. (NASDAQ: HUGE) (FSD Pharma or the Company), today announced it has entered into definitive agreements with certain institutional investors for the purchase and sale of 1,500,000 shares of the Companys Class B Subordinate Voting Shares (Shares) at a price of C$6.75 per Share pursuant to a private placement resulting in gross proceeds of approximately C$10.125 million.
- The Company has also agreed to issue common share purchase warrants to purchase 1,500,000 Shares of the Company.
- The proceeds are expected to be used for working capital and other general corporate purposes.
- FSD Pharma Inc. (Nasdaq: HUGE; CSE: HUGE.CN; FRA: 0K9A) is a publicly traded holding company, since May 2018.